Biofarm S.A. manufactures pharmaceutical products. The company's products include cardiovascular, digestive and metabolic, genito-urinary, ophthalmological, endocrine, nervous system, osteo-muscular, respiratory and ENT, multivitamin, antiallergen, and dermatological products. Biofarm S.A. was founded in 1921 and is based in Bucharest, Romania. As of June 24, 2026, Biofarm S.A. operates as a subsidiary of Polpharma SA Pharmaceutical Works.
Frequently asked questions
What sector does Biofarm Bucure (BIO) operate in?
Biofarm Bucure belongs to the Other sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Biofarm Bucure (BIO) current stock price?
As of the latest data, Biofarm Bucure stock price is RON 1.34, with a previous close of RON 1.33. Biofarm Bucure gained RON 0.01 in the last trading session, representing a 0.75% increase.
What is Biofarm Bucure (BIO) current market capitalization?
Biofarm Bucure market cap is approximately 1.32 billion.
What is Biofarm Bucure (BIO) Earnings Per Share (EPS)?
The trailing EPS is RON 0.09.
What is Biofarm Bucure (BIO) Price-to-Earnings (P/E) ratio?
Biofarm Bucure current P/E ratio is 14.83.
Does Biofarm Bucure (BIO) pay dividends?
Yes. Biofarm Bucure pays semiannual dividends with an annualized yield of 21.01% and an estimated annual payout of RON 0.28 per share.
When is the next ex-dividend date for Biofarm Bucure (BIO)?
The next ex-dividend date is scheduled for December 29, 2026.
What is Biofarm Bucure (BIO) beta (volatility) score?
Biofarm Bucure has a beta of 0.505, indicating lower volatility than the overall market.